{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:26:43Z","timestamp":1791638803524,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008676","name":"CMC Microsystems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","award":["GPP 2022"],"award-info":[{"award-number":["GPP 2022"]}],"id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","seizure-journal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.seizure.2023.06.004","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T16:03:39Z","timestamp":1686153819000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to &lt;12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis"],"prefix":"10.1016","volume":"110","author":[{"given":"Hirowo","family":"Omatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaeko","family":"Ishiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8184-1367","authenticated-orcid":false,"given":"Leock Y","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2023.06.004_bib0001","first-page":"267","article-title":"Epidemiology and the genetics of epilepsy","volume":"61","author":"Hauser","year":"1983","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10.1016\/j.seizure.2023.06.004_bib0002","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40263-015-0281-8","article-title":"Antiepileptic drug treatment in children with epilepsy","volume":"29","author":"Rosati","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2023.06.004_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/JRLCR.S51475","article-title":"The AMPA receptor as a therapeutic target in epilepsy: preclinical and clinical evidence","volume":"7","author":"Hanada","year":"2014","journal-title":"J Receptor Ligand Channel Res"},{"key":"10.1016\/j.seizure.2023.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.06.004_bib0006","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.06.004_bib0007","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.06.004_bib0008","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.06.004_bib0009","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ane.12883","article-title":"Adjunctive perampanel in partial-onset seizures: Asia-pacific, randomized phase III study","volume":"137","author":"Nishida","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2023.06.004_bib0010","unstructured":"European Medicine Agency. Concept paper on extrapolation of efficacy and safety in medicine development, https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/concept-paper-extrapolation-efficacy-safety-medicine-development_en.pdf; March 2013 [last updated March 2013; accessed March 1, 2022]."},{"key":"10.1016\/j.seizure.2023.06.004_bib0011","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). General clinical pharmacology considerations for pediatric studies for drugs and biological products guidance for industry, https:\/\/www.fda.gov\/media\/90358\/download; December 2014 [last updated December 2014; accessed March 1, 2022]."},{"key":"10.1016\/j.seizure.2023.06.004_bib0012","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/WNL.0b013e31826d5ec0","article-title":"Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review","volume":"79","author":"Pellock","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.06.004_bib0013","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/epi.13859","article-title":"Extrapolating evidence of antiepileptic drug efficacy in adults to children \u22652 years of age with focal seizures: the case for disease similarity","volume":"58","author":"Pellock","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.06.004_bib0014","unstructured":"Food and Drug Administration, U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER). Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 2 years of age and older. Guidance for industry, https:\/\/www.fda.gov\/media\/130449\/download; September 2019 [last updated September 2019; accessed March 18, 2022]."},{"key":"10.1016\/j.seizure.2023.06.004_bib0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/epi.16413","article-title":"Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures","volume":"61","author":"Fogarasi","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.06.004_bib0016","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.seizure.2023.06.004_bib0019","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/0883073819827407","article-title":"Adjunctive perampanel oral suspension in pediatric patients from \u22652 to <12 years of age with epilepsy: pharmacokinetics, safety, tolerability, and efficacy","volume":"34","author":"Renfroe","year":"2019","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2023.06.004_bib0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the commission on classification and terminology of the international league against epilepsy","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.06.004_bib0021","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International league against epilepsy: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.06.004_bib0022","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.seizure.2023.06.004_bib0023","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0920-1211(00)00198-4","article-title":"The A\u2013B neuropsychological assessment schedule (ABNAS): the further refinement of a patient\u2013based scale of patient\u2013perceived cognitive functioning","volume":"43","author":"Brooks","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2023.06.004_bib0017","unstructured":"Food and Drug Administration (FDA). Fycompa\u00ae prescribing information, https:\/\/www.fycompa.com\/hcp\/-\/media\/Files\/Fycompa\/Fycompa_Prescribing_Information.pdf ; December 2021 [last updated December 2021; accessed March 1, 2022]."},{"key":"10.1016\/j.seizure.2023.06.004_bib0024","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ane.12874","article-title":"Pharmacokinetic\/pharmacodynamic analysis of adjunctive perampanel in subjects with partial\u2013onset seizures","volume":"137","author":"Takenaka","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2023.06.004_bib0025","article-title":"Efficacy and tolerability of perampanel as adjunctive therapy in Chinese patients with focal\u2013onset seizures: an observational, prospective study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Neurol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123001577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123001577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T16:42:48Z","timestamp":1722616968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131123001577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":23,"alternative-id":["S1059131123001577"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2023.06.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to <12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2023.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}